Rhythm Pharmaceuticals In...

NASDAQ: RYTM · Real-Time Price · USD
97.69
1.21 (1.25%)
At close: Aug 15, 2025, 3:59 PM
97.50
-0.19%
After-hours: Aug 15, 2025, 06:27 PM EDT

Rhythm Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-183.1M -168.73M -260.6M -258.94M -259.43M -273.87M -184.68M -185.54M -182.24M -180.53M -181.12M -181.49M -175.74M -166.13M -69.61M -61.64M -60.35M -56.08M
Depreciation & Amortization
1.53M 1.54M 1.56M 1.6M 1.66M 1.71M 1.76M 1.78M 1.78M 1.78M 1.67M 1.55M 1.43M 1.31M 1.16M 1.01M 868K 724K
Stock-Based Compensation
50.3M 44.78M 39.68M 37.8M 35.41M 33.94M 32.55M 29.17M 25.35M 21.6M 19.83M 19.22M 19.69M 20.22M 20.8M 20.39M 19.81M 17.17M
Other Working Capital
-4.87M -1.11M 2.05M 8.21M 8.81M 3.45M 4.38M -4.4M -6.76M -713K -6.13M -10.06M -16.31M -23.78M -16.41M -1.1M 8.45M 9.72M
Other Non-Cash Items
9.01M 21.49M 121.86M 122.68M 123.21M 115.06M 19.38M 18.13M 17.98M 14.48M 5.91M 2.97M -212K -254K -100.25M -100.25M -100.24M -100.24M
Deferred Income Tax
n/a n/a n/a -9.88M -10.11M -9.97M -9.97M -100K 135K n/a n/a -7.99M -16.98M -22.01M n/a 7.99M 16.98M 22.01M
Change in Working Capital
14.54M 4.49M 10.21M 8.91M 7.4M 2.21M 4.81M -4.22M -21.52M -13.55M -19.72M -14.16M -1.26M 751K 1.9M -2.15M 1.41M -2.99M
Operating Cash Flow
-107.72M -113.49M -113.88M -124.42M -128.45M -140.47M -136.16M -140.77M -158.51M -156.23M -173.43M -179.9M -173.07M -166.1M -146M -134.65M -121.52M -119.41M
Capital Expenditures
40M 40M n/a 1K -40M -40.88M -922K -922K -1.02M -4.2M -4.28M -4.35M -4.36M -5.55M -5.43M -5.45M -5.47M -226K
Cash Acquisitions
n/a n/a n/a -22.64M -22.64M -21.76M -21.76M 875K 40.48M 39.6M 39.6M 39.6M n/a 5M 105M 105M 105M 100M
Purchase of Investments
-262.48M -301.83M -268.31M -242.59M -276.15M -285.27M -354.92M -414.68M -346.57M -282.1M -251.94M -220.25M -212.94M -266.91M -524.97M -489.71M -405.93M -369.04M
Sales Maturities Of Investments
272.16M 248.92M 260.64M 236.4M 265.59M 332.34M 354.97M 351.31M 338.29M 264.79M 284.25M 293.66M 388.83M 421.53M 361.25M 387.64M 276.01M 253.21M
Other Investing Acitivies
n/a -8.56M -48.56M -25.92M -26.2M -18.51M 16.97M -5.67M -45M -8.08M 69.09M 76.09M 178.57M 137.53M 164.89M 219.86M 192.01M 229.87M
Investing Cash Flow
9.19M -53.41M -48.17M -46.69M -50.83M 5.92M -5.67M -69.08M -13.82M -26.03M 28.03M 76.05M 178.53M 156.07M -62.16M -7.52M -35.39M -16.05M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-2.67M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
74.25M 185.46M 191.24M 155.34M 225.89M 78.4M 74.03M 74.83M 43.38M 82.18M 82.72M 79.59M 38.41M 1.29M 4.75M 5.07M 5.36M 5.16M
Financial Cash Flow
72.43M 219.5M 191.24M 155.34M 225.89M 78.74M 74.37M 89.31M 174.83M 213.3M 213.83M 196.56M 38.41M 1.29M 166.48M 166.8M 167.09M 166.89M
Net Cash Flow
-25.56M 53.13M 29.52M -16.61M 45.98M -56.23M -67.6M -120.49M 2.48M 31.12M 68.43M 92.72M 43.87M -8.73M -41.68M 24.63M 10.17M 31.42M
Free Cash Flow
-67.72M -73.49M -113.88M -124.42M -168.45M -181.34M -137.08M -141.7M -159.53M -160.43M -177.71M -184.25M -177.43M -171.65M -151.44M -140.1M -127M -119.64M